Faeth Therapeutics names two SVPs ahead of clinical milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Faeth Therapeutics names two SVPs ahead of clinical milestones

Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments

August 14, 2026 7:30 AM EDT

Appointments reinforce technical operations and investor engagement as the company advances its clinical programs

AUSTIN, Texas--(BUSINESS WIRE)-- Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced the appointments of Deepak Tiwari as Senior Vice President, Technical Operations, and Matt Biegler as Senior Vice President, Investor Relations, as the company prepares for upcoming PIKTOR clinical milestones.

Tiwari will lead Faeths technical operations organization, overseeing chemistry, manufacturing and controls (CMC), and supply chain activities supporting the companys PIKTOR clinical development program and potential future commercialization. Biegler will lead the companys... More